期刊
MOLECULAR PHARMACEUTICS
卷 11, 期 3, 页码 974-981出版社
AMER CHEMICAL SOC
DOI: 10.1021/mp400624v
关键词
blood-brain barrier (BBB); permeability; magnetic resonance imaging (MRI); E-cadherin peptide (HAV); near infrared fluorescence imaging (NIRF); gadolinium diethylenetriaminepentaacetate (Gd-DTPA) contrast agent; rhodamine 800 (R800); IRDye 800CW PEG; P-glycoprotein (P-gp)
资金
- National Institutes of Health [R01-NS-075374]
- Natural Science and Engineering Research Council of Canada [RGPIN-371699]
The present work characterizes the effects of synthetic E-cadherin peptide (HAV) on blood brain barrier (BBB) integrity using various techniques including magnetic resonance imaging (MRI) and near-infrared fluorescent imaging (NIRF). The permeability of small molecular weight permeability marker gadolinium diethylenetriaminepentaacetate (Gd-DTPA) contrast agent, the large molecular weight permeability marker, IRDye 800CW PEG, and the P-glycoprotein (P-gp) efflux transporter contrast agent, rhodamine 800 (R800), were examined in the presence and absence of HAV peptide. The results consistently demonstrated that systemic iv administration of HAV peptide resulted in a reversible disruption of BBB integrity and enhanced the accumulation of all the dyes examined. The magnitude of increase ranged from 2-fold to 5-fold depending on the size and the properties of the permeability markers. The time frame for BBB disruption with HAV peptide was rapid, occurring within 3-6 min following injection of the peptide. Furthermore, modulation of BBB permeability was reversible with the barrier integrity being restored within 60 min of the injection. The increased BBB permeability observed following HAV peptide administration was not attributable to changes in cerebral blood flow. These studies support the potential use of cadherin peptides to rapidly and reversibly modulate BBB permeability of a variety of therapeutic agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据